Canada Pension Plan Investment Board Eagle Pharmaceuticals, Inc. Transaction History

Canada Pension Plan Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$37.02 - $51.28 $25,914 - $35,896	-700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $30,268 - $38,514	700 New	700 $34,000
Q3 2019 Nov 12, 2019	SELL	$53.25 - $59.98 $407,256 - $458,727	-7,648 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$46.61 - $58.45 $176,605 - $221,467	-3,789 Reduced 33.13%	7,648 $426,000
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $381,303 - $511,100	-9,863 Reduced 46.31%	11,437 $577,000
Q4 2018 Feb 06, 2019	SELL	$36.72 - $67.73 $470,016 - $866,944	-12,800 Reduced 37.54%	21,300 $858,000
Q3 2018 Nov 09, 2018	BUY	$66.65 - $83.86 $2.19 Million - $2.75 Million	32,800 Added 2523.08%	34,100 $2.36 Million
Q2 2018 Aug 07, 2018	BUY	$51.25 - $76.62 $66,625 - $99,606	1,300 New	1,300 $98,000

9.89M

1.01M

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $51.4M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.